Chronic Fatigue Syndrome, Fibromyalgia
Conditions
Brief summary
The study will explore if Recovery Factors improve symptoms in fibromyalgia and chronic fatigue syndrome
Detailed description
Subjects will receive four tablets twice a day (three times a day for five day loading dose), taking the treatment for 5 - 6 weeks. Subjects will receive four tablets twice a day (three times a day for five day loading dose), taking the treatment for 5 - 6 weeks. The treatment is a unique nutritional peptide mix derived from porcine serum
Interventions
DIETARY_SUPPLEMENTRecovery Factors
Porcine serum amino acid/peptide
Sponsors
Practitioners Alliance Network
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Open pilot study to assess efficacy and antibody effects
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Meet ACR 2010 amended Fibromyalgia criteria or CDC CFS Criteria Overall well being score of 5 of less (on 0-10 VAS)
Exclusion criteria
Pregnant Clotting disorders \-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| VAS | 6 weeks | Composite VAS (1-10) for Fatigue, Pain, Cognition, Sleep and overall well-being |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| antibody titres | 10 weeks | Total IgG and IgG 1-4 subsets |
| FIQ-R | 6 weeks | Fibromyalgia severity scale |
Countries
United States
Outcome results
None listed